Literature DB >> 23493163

Oral vaccines: directed safe passage to the front line of defense.

Qing Zhu1, Jay A Berzofsky.   

Abstract

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. We recently found in animal models that formulation of oral vaccines in a nanoparticle-releasing microparticle delivery system is a viable approach for selectively inducing large intestinal protective immunity against infections at rectal and genital mucosae. These large-intestine targeted oral vaccines are a potential substitute for the intracolorectal immunization, which has been found to be effective against rectogenital infections but is not feasible for mass vaccination. Moreover, the newly developed delivery system can be modified to selectively target either the small or large intestine for immunization and accordingly revealed a regionalized immune system in the gut. Future applications and research endeavors suggested by the findings are discussed.

Entities:  

Keywords:  T cell; intestine; mucosa; nanoparticle; oral vaccine; rectogenital infection

Mesh:

Substances:

Year:  2013        PMID: 23493163      PMCID: PMC3669171          DOI: 10.4161/gmic.24197

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  50 in total

Review 1.  Epithelial M cells: differentiation and function.

Authors:  J P Kraehenbuhl; M R Neutra
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

2.  Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores.

Authors:  Hugues Lelouard; Mathieu Fallet; Béatrice de Bovis; Stéphane Méresse; Jean-Pierre Gorvel
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

Review 3.  Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.

Authors:  Bert Devriendt; Bruno G De Geest; Bruno M Goddeeris; Eric Cox
Journal:  J Control Release       Date:  2012-02-13       Impact factor: 9.776

4.  Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

Authors:  Elizabeth Furrie; Sandra Macfarlane; George Thomson; George T Macfarlane
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

5.  Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

Authors:  Qing Zhu; Colt Egelston; Susan Gagnon; Yongjun Sui; Igor M Belyakov; Dennis M Klinman; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

Review 6.  Designing oral vaccines targeting intestinal dendritic cells.

Authors:  Bert Devriendt; Bruno G De Geest; Eric Cox
Journal:  Expert Opin Drug Deliv       Date:  2011-03-05       Impact factor: 6.648

7.  The jejunal Peyer's patches are the major inductive sites of the F4-specific immune response following intestinal immunisation of pigs with F4 (K88) fimbriae.

Authors:  V Snoeck; T Verfaillie; F Verdonck; B M Goddeeris; E Cox
Journal:  Vaccine       Date:  2005-08-01       Impact factor: 3.641

8.  A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.

Authors:  Igor M Belyakov; Dmitry Isakov; Qing Zhu; Amiran Dzutsev; Jay A Berzofsky
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

9.  CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease.

Authors:  S J Connor; N Paraskevopoulos; R Newman; N Cuan; T Hampartzoumian; A R Lloyd; M C Grimm
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

10.  Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection.

Authors:  Qing Zhu; James Talton; Guofeng Zhang; Tshaka Cunningham; Zijian Wang; Robert C Waters; James Kirk; Bärbel Eppler; Dennis M Klinman; Yongjun Sui; Susan Gagnon; Igor M Belyakov; Russell J Mumper; Jay A Berzofsky
Journal:  Nat Med       Date:  2012-07-15       Impact factor: 53.440

View more
  8 in total

Review 1.  Vaccination against Salmonella Infection: the Mucosal Way.

Authors:  Rémi Gayet; Gilles Bioley; Nicolas Rochereau; Stéphane Paul; Blaise Corthésy
Journal:  Microbiol Mol Biol Rev       Date:  2017-06-14       Impact factor: 11.056

2.  Oral Administration of Recombinant Saccharomyces boulardii Expressing Ovalbumin-CPE Fusion Protein Induces Antibody Response in Mice.

Authors:  Ghasem Bagherpour; Hosnie Ghasemi; Bahare Zand; Najmeh Zarei; Farzin Roohvand; Esmat M Ardakani; Mohammad Azizi; Vahid Khalaj
Journal:  Front Microbiol       Date:  2018-04-13       Impact factor: 5.640

Review 3.  Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development.

Authors:  Balraj Premanand; Poh Zhong Wee; Mookkan Prabakaran
Journal:  Viruses       Date:  2018-05-31       Impact factor: 5.048

4.  Rapid production of a chimeric antibody-antigen fusion protein based on 2A-peptide cleavage and green fluorescent protein expression in CHO cells.

Authors:  Hans Van der Weken; Eric Cox; Bert Devriendt
Journal:  MAbs       Date:  2019-02-26       Impact factor: 5.857

Review 5.  Microparticles and Nanoparticles from Plants-The Benefits of Bioencapsulation.

Authors:  Jennifer Schwestka; Eva Stoger
Journal:  Vaccines (Basel)       Date:  2021-04-11

6.  Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice.

Authors:  Lilin Zhang; Lan Yao; Yanyu Guo; Xiaoyang Li; Li Ma; Ruiqi Sun; Xueqing Han; Jing Liu; Jinhai Huang
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 6.064

7.  Oral Immunization With a M Cell-Targeting Recombinant L. Lactis Vaccine LL-plSAM-FVpE Stimulate Protective Immunity Against H. Pylori in Mice.

Authors:  Le Guo; Furui Zhang; Shue Wang; Runle Li; Lele Zhang; Zhen Zhang; Runting Yin; Hongpeng Liu; Kunmei Liu
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

8.  A Common Food Glycan, Pectin, Shares an Antigen with Streptococcus pneumoniae Capsule.

Authors:  Moon H Nahm; Jigui Yu; Jiri Vlach; Maor Bar-Peled
Journal:  mSphere       Date:  2020-04-08       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.